Similar articles

• Immunotherapy of a murine sarcoma using specific antitumor immune RNA.

  Webster DJ, Cornacoff JB, Vallera DA, Dalmasso JP, Dodd MC, Minton JP. Webster DJ, et al. J Surg Oncol. 1979;12(3):213-20. doi: 10.1002/jso.2930120305. J Surg Oncol. 1979. PMID: 502564
• Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.

  Veltman LL, Kern DH, Pilch YH. Veltman LL, et al. Am J Obstet Gynecol. 1974 Aug 1;119(7):959-65. doi: 10.1016/0002-9378(74)90015-5. Am J Obstet Gynecol. 1974. PMID: 4135321 No abstract available.
• Antitumor antibody synthesis in vitro induced in mouse spleen cells by xenogeneic immune RNA.

  Kern DH, Pilch YH. Kern DH, et al. J Natl Cancer Inst. 1978 Mar;60(3):599-603. doi: 10.1093/jnci/60.3.599. J Natl Cancer Inst. 1978. PMID: 625065 No abstract available.
• Transfer of antitumor immunity by "immune" RNA.

  Pilch YH, Fritze D, Waldman SR, Kern DH. Pilch YH, et al. Curr Top Microbiol Immunol. 1975;72:157-90. doi: 10.1007/978-3-642-66289-8_5. Curr Top Microbiol Immunol. 1975. PMID: 767056 Review. No abstract available.
• Lymphocyte-mediated immune responses in neoplasia.

  Pilch YH, Golub SH. Pilch YH, et al. Am J Clin Pathol. 1974 Aug;62(2):184-211. doi: 10.1093/ajcp/62.2.184. Am J Clin Pathol. 1974. PMID: 4602086 Review. No abstract available.